DENNIS LANGER Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DENNIS LANGER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DENNIS LANGER. DENNIS LANGER is a Director in PERNIX THERAPEUTICS HOLDINGS, INC. ($GTA) and a Director in MYRIAD GENETICS INC ($MYGN) and a Director in DELCATH SYSTEMS, INC. ($DCTH) and a in Dicerna Pharmaceuticals Inc ($DRNA) and a Director in Dicerna Pharmaceuticals Inc ($DRNA).
Address: 320 WAKARA WAY SALT LAKE CITY 84108 UT
Companies in which DENNIS LANGER is an Insider
DELCATH SYSTEMS, INC.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of DENNIS LANGER: Director
Holdings: 20,000 shares
Current Value: $5,000
Latest Transaction: Jun 12 2015
$DCTH Market Capitalization: $527280.00
$DCTH Previous Close: $0.25
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Dicerna Pharmaceuticals Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DENNIS LANGER: Director
Holdings: 47,978 shares
Current Value: $123,783
Latest Transaction: Jun 21 2019
$DRNA Market Capitalization: $50.84M
$DRNA Previous Close: $2.58
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MYRIAD GENETICS INC
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of DENNIS LANGER: Director
Holdings: 89,527 shares
Current Value: $1,378,716
Latest Transaction: Jun 04 2021
$MYGN Market Capitalization: $1.13B
$MYGN Previous Close: $15.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PERNIX THERAPEUTICS HOLDINGS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DENNIS LANGER: Director
Holdings: 0 shares
Latest Transaction: May 23 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of DENNIS LANGER
Sentiment: All, DCTH, DRNA, MYGN, GTA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 04 2021 | MYGN | MYRIAD GENETICS IN ... | LANGER DENNIS | Director | Grant | A | 0.00 | 12,848 | 0 | 89,527 | 76.7 K to 89.5 K (+16.76 %) |
| Dec 07 2020 | MYGN | MYRIAD GENETICS IN ... | LANGER DENNIS | Director | Grant | A | 0.00 | 15,889 | 0 | 76,679 | 60.8 K to 76.7 K (+26.14 %) |
| Dec 06 2019 | MYGN | MYRIAD GENETICS IN ... | LANGER DENNIS | Director | Grant | A | 0.00 | 11,687 | 0 | 60,790 | 49.1 K to 60.8 K (+23.80 %) |
| Jun 21 2019 | DRNA | Dicerna Pharmaceut ... | LANGER DENNIS | Director | Option Exercise | A | 15.44 | 25,000 | 386,000 | 25,000 | |
| Nov 30 2018 | MYGN | MYRIAD GENETICS IN ... | LANGER DENNIS | Director | Grant | A | 0.00 | 9,360 | 0 | 49,103 | 39.7 K to 49.1 K (+23.55 %) |
| Aug 17 2018 | DRNA | Dicerna Pharmaceut ... | LANGER DENNIS | Sell | S | 16.00 | 14,531 | 232,496 | 29,064 | 43.6 K to 29.1 K (-33.33 %) | |
| Aug 17 2018 | DRNA | Dicerna Pharmaceut ... | LANGER DENNIS | Sell | S | 16.00 | 23,810 | 380,960 | 47,978 | 71.8 K to 48 K (-33.17 %) |